1. Home
  2. IMNM vs BOSC Comparison

IMNM vs BOSC Comparison

Compare IMNM & BOSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • BOSC
  • Stock Information
  • Founded
  • IMNM 2006
  • BOSC 1990
  • Country
  • IMNM United States
  • BOSC Israel
  • Employees
  • IMNM N/A
  • BOSC N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • BOSC Computer Communications Equipment
  • Sector
  • IMNM Health Care
  • BOSC Telecommunications
  • Exchange
  • IMNM Nasdaq
  • BOSC Nasdaq
  • Market Cap
  • IMNM 748.3M
  • BOSC 28.4M
  • IPO Year
  • IMNM 2020
  • BOSC 1996
  • Fundamental
  • Price
  • IMNM $8.63
  • BOSC $5.02
  • Analyst Decision
  • IMNM Strong Buy
  • BOSC
  • Analyst Count
  • IMNM 5
  • BOSC 0
  • Target Price
  • IMNM $26.40
  • BOSC N/A
  • AVG Volume (30 Days)
  • IMNM 1.0M
  • BOSC 135.5K
  • Earning Date
  • IMNM 08-11-2025
  • BOSC 08-21-2025
  • Dividend Yield
  • IMNM N/A
  • BOSC N/A
  • EPS Growth
  • IMNM N/A
  • BOSC 35.10
  • EPS
  • IMNM N/A
  • BOSC 0.49
  • Revenue
  • IMNM $10,938,000.00
  • BOSC $43,688,000.00
  • Revenue This Year
  • IMNM N/A
  • BOSC N/A
  • Revenue Next Year
  • IMNM $310.65
  • BOSC N/A
  • P/E Ratio
  • IMNM N/A
  • BOSC $10.17
  • Revenue Growth
  • IMNM N/A
  • BOSC 0.84
  • 52 Week Low
  • IMNM $5.15
  • BOSC $2.50
  • 52 Week High
  • IMNM $16.81
  • BOSC $5.50
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 47.25
  • BOSC 63.45
  • Support Level
  • IMNM $8.46
  • BOSC $4.66
  • Resistance Level
  • IMNM $9.34
  • BOSC $5.10
  • Average True Range (ATR)
  • IMNM 0.53
  • BOSC 0.26
  • MACD
  • IMNM -0.09
  • BOSC -0.01
  • Stochastic Oscillator
  • IMNM 20.00
  • BOSC 85.92

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About BOSC B.O.S. Better Online Solutions

BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.

Share on Social Networks: